Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WaferGen Biosystems is a life science tools company that specializes in high-throughput genomic analysis and single-cell research. The company is best known for its ICell8 Single-Cell System, which allows for the isolation and analysis of thousands of single cells, and its SmartChip Real-Time PCR System for high-throughput gene expression and genotyping. These technologies enable researchers to perform large-scale genomic studies with high precision and efficiency. In 2017, WaferGen was acquired by Takara Bio to enhance its portfolio in the rapidly growing single-cell analysis market. Today, its core technologies continue to be marketed and developed under the Takara Bio brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WaferGen Biosystems.